Modulation of phosphorylation of tocopherol and phosphatidylinositol by hTAP1/SEC14L2-mediated lipid exchange

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Zingg, Jean Marc ^a   Libinaki, Roksan ^b   Meydani, Mohsen ^a   Azzi, Angelo ^a  

^a TUFTS UNIVERSITY   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHERYL PHOSPHATE; BINDING PROTEIN; CD36 ANTIGEN; HUMAN TOCOPHEROL ASSOCIATED PROTEIN 1; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHORUS 32; RECOMBINANT PROTEIN; SCAVENGER RECEPTOR; TOCOPHEROL; UNCLASSIFIED DRUG; VASCULOTROPIN; CARRIER PROTEIN; LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3R3 PROTEIN, HUMAN; SEC14L2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; ESCHERICHIA COLI; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID EXCHANGE; LIPID METABOLISM; MONOCYTE; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; SEPARATION TECHNIQUE; SMOOTH MUSCLE FIBER; THIN LAYER CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VEGF GENE; WESTERN BLOTTING; CORONARY BLOOD VESSEL; CYTOLOGY; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VASCULAR SMOOTH MUSCLE;

CARRIER PROTEINS; CELL LINE, TUMOR; CORONARY VESSELS; HUMANS; LIPID METABOLISM; LIPOPROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOLS; PHOSPHORYLATION; TOCOPHEROLS; TRANS-ACTIVATORS;

EID: 84903642437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101550     Document Type: Article

References (70)

1. Nakayama S, Katoh EM, Tsuzuki T, Kobayashi S (2003) Protective effect of alpha-tocopherol-6-O-phosphate against ultraviolet B-induced damage in cultured mouse skin. J Invest Dermatol 121: 406-411.
2. Negis Y, Zingg JM, Ogru E, Gianello R, Libinaki R, et al. (2005) On the existence of cellular tocopheryl phosphate, its synthesis, degradation and cellular roles: a hypothesis. IUBMB Life 57: 23-25.
3. Gianello R, Libinaki R, Azzi A, Gavin PD, Negis Y, et al. (2005) Alpha-tocopheryl phosphate: a novel, natural form of vitamin E. Free Radic Biol Med 39: 970-976.
4. Zingg JM, Libinaki R, Lai CQ, Meydani M, Gianello R, et al. (2010) Modulation of gene expression by alpha-tocopherol and alpha-tocopheryl phosphate in THP-1 monocytes. FRBM 49: 1989-2000.
5. Kagan VE, Bakalova RA, Serbinova EE, Stoytchev TS (1990) Fluorescence measurements of incorporation and hydrolysis of tocopherol and tocopheryl esters in biomembranes. Methods Enzymol 186: 355-367.
6. Nishio K, Ishida N, Saito Y, Ogawa-Akazawa Y, Shichiri M, et al. (2011) alpha-Tocopheryl phosphate: Uptake, hydrolysis, and antioxidant action in cultured cells and mouse. Free Radic Biol Med 50: 1794-1800.
7. Zingg JM, Azzi A (2006) Molecular Activities of Vitamin E. In: Meskin MS, Bidlack WR, Randolph RK,editors. Phytochemicals: Nutrient-Gene Interactions: Taylor&Francis. pp. 175-206.
8. Ames SR, Risley HA (1949) Effects of tocopherols and their phosphates on enzyme systems. Annals of the New York Academy of Sciences 52: 149155.
9. Zingg JM, Meydani M, Azzi A (2010) alpha-Tocopheryl phosphate - An active lipid mediator? Mol Nutr Food Res 54: 1-14.
10. Negis Y, Aytan N, Ozer N, Ogru E, Libinaki R, et al. (2006) The effect of tocopheryl phosphates on atherosclerosis progression in rabbits fed with a high cholesterol diet. Arch Biochem Biophys 450: 63-66.
11. Libinaki R, Tesanovic S, Heal A, Nikolovski B, Vinh A, et al. (2010) The Effect of Tocopheryl Phosphate on Key Biomarkers of Inflammation: Implication in the reduction of atherosclerosis progression in a hypercholesterolemic rabbit model. Clin Exp Pharmacol Physiol 37: 587-592.
12. Negis Y, Meydani M, Zingg JM, Azzi A (2007) Molecular mechanism of alpha-tocopheryl-phosphate transport across the cell membrane. Biochem Biophys Res Commun 359: 348-353.
13. McCary CA, Yoon Y, Panagabko C, Cho W, Atkinson J, et al. (2012) Vitamin E isoforms directly bind PKCalpha and differentially regulate activation of PKCalpha. Biochem J 441: 189-198.
14. Ni J, Wen X, Yao J, Chang HC, Yin Y, et al. (2005) Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res 65: 9807-9816.
15. Shiau CW, Huang JW, Wang DS, Weng JR, Yang CC, et al. (2006) alpha - Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of BCL-XL/BCL-2 function. J Biol Chem 281: 11819-11825.
16. Neuzil J, Dong LF, Wang XF, Zingg JM (2006) Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells. Biochem Biophys Res Commun 343: 1113-1117.
17. Rigotti A (2007) Absorption, transport, and tissue delivery of vitamin E. Molecular Aspects of Medicine 28: 423-436.
18. Bankaitis VA, Vincent P, Merkulova M, Tyeryar K, Liu Y (2007) Phosphatidylinositol transfer proteins and functional specification of lipid signaling pools. Adv Enzyme Regul 47: 27-40.
19. Saito K, Tautz L, Mustelin T (2007) The lipid-binding SEC14 domain. Biochim Biophys Acta 1771: 719-726.
20. Ghosh R, Bankaitis VA (2011) Phosphatidylinositol transfer proteins: negotiating the regulatory interface between lipid metabolism and lipid signaling in diverse cellular processes. Biofactors 37: 290-308.
21. Cockcroft S, Garner K (2011) Function of the phosphatidylinositol transfer protein gene family: is phosphatidylinositol transfer the mechanism of action? Crit Rev Biochem Mol Biol 46: 89-117.
22. Kearns BG, Alb JG, Bankaitis V (1998) Phosphatidylinositol transfer proteins: the long and winding road to physiological function. Trends Cell Biol 8: 276-282.
23. Ile KE, Schaaf G, Bankaitis VA (2006) Phosphatidylinositol transfer proteins and cellular nanoreactors for lipid signaling. Nat Chem Biol 2: 576-583.
24. Upadhyay J, Misra K (2009) Towards the interaction mechanism of tocopherols and tocotrienols (vitamin E) with selected metabolizing enzymes. Bioinformation 3: 326-331.
25. Panagabko C, Morley S, Hernandez M, Cassolato P, Gordon H, et al. (2003) Ligand specificity in the CRAL-TRIO protein family. Biochemistry 42: 6467-6474.
26. Kempna P, Zingg JM, Ricciarelli R, Hierl M, Saxena S, et al. (2003) Cloning of novel human SEC14p-like proteins: cellular localization, ligand binding and functional properties. Free Radic Biol Med 34: 1458-1472.
27. Kempna P, Cipollone R, Villacorta L, Ricciarelli R, Zingg JM (2003) Isoelectric point mobility shift assay for rapid screening of charged and uncharged ligands bound to proteins. IUBMB Life 55: 103-107.
28. Zingg JM, Kempna P, Paris M, Reiter E, Villacorta L, et al. (2008) Characterization of three human sec14p-like proteins: alpha-Tocopherol transport activity and expression pattern in tissues. Biochimie 90: 1703-1715.
29. Shibata N, Arita M, Misaki Y, Dohmae N, Takio K, et al. (2001) Supernatant protein factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer protein and enhances cholesterol biosynthesis. Proc Natl Acad Sci USA 98: 2244-2249.
30. Mokashi V, Singh DK, Porter TD (2005) Supernatant protein factor stimulates HMG-CoA reductase in cell culture and in vitro. Arch Biochem Biophys 433: 474-480.
31. Munteanu A, Zingg JM, Ogru E, Libinaki R, Gianello R, et al. (2004) Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Biochem Biophys Res Commun 318: 311-316.
32. Ricciarelli R, Zingg JM, Azzi A (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured human aortic smooth muscle cells. Circulation 102: 82-87.
33. Kempna P, Reiter E, Arock M, Azzi A, Zingg JM (2004) Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway. J Biol Chem 279: 50700-50709.
34. van den Hoff MJ, Moorman AF, Lamers WH (1992) Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res 20: 2902.
35. Prior SJ, Hagberg JM, Paton CM, Douglass LW, Brown MD, et al. (2006) DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am J Physiol Heart Circ Physiol 290: H1848-1855.
36. Munteanu A, Ricciarelli R, Massone S, Zingg JM (2007) Modulation of Proteasome Activity by Vitamin E in THP-1 Monocytes. IUBMB Life 59: 771-780.
37. Zingg JM (2007) Molecular and cellular activities of vitamin E analogues. Mini Reviews in Medicinal Chemistry 7: 543-558.
38. Smolarek AK, Suh N (2011) Chemopreventive activity of vitamin E in breast cancer: a focus on gamma- and delta-tocopherol. Nutrients 3: 962-986.
39. Birringer M (2010) Analysis of vitamin E metabolites in biological specimen. Mol Nutr Food Res 54: 588-598.
40. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, et al. (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11: 936-943.
41. Dutra RC, Cola M, Leite DF, Bento AF, Claudino RF, et al. (2011) Inhibitor of PI3Kgamma ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells. Br J Pharmacol 163: 358-374.
42. Schaaf G, Ortlund EA, Tyeryar KR, Mousley CJ, Ile KE, et al. (2008) Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the sec14 superfamily. Mol Cell 29: 191-206.
43. Nile AH, Bankaitis VA, Grabon A (2010) Mammalian diseases of phosphatidylinositol transfer proteins and their homologs. Clin Lipidol 5: 867-897.
44. Kono N, Ohto U, Hiramatsu T, Urabe M, Uchida Y, et al. (2013) Impaired alpha-TTP-PIPs Interaction Underlies Familial Vitamin E Deficiency. Science.
45. Curwin AJ, Leblanc MA, Fairn GD, McMaster CR (2013) Localization of lipid raft proteins to the plasma membrane is a major function of the phospholipid transfer protein sec14. PLoS One 8: e55388.
46. Huang PH, Chuang HC, Chou CC, Wang H, Lee SL, et al. (2013) Vitamin E Facilitates the Inactivation of the Kinase Akt by the Phosphatase PHLPP1. Sci Signal 6: ra19.
47. Munteanu A, Taddei M, Tamburini I, Bergamini E, Azzi A, et al. (2006) Antagonistic Effects of Oxidized Low Density Lipoprotein and {alpha}-Tocopherol on CD36 Scavenger Receptor Expression in Monocytes: INVOLVEMENT OF PROTEIN KINASE B AND PEROXISOME PRO-LIFERATOR- ACTIVATED RECEPTOR-{gamma}. J Biol Chem 281: 6489-6497.
48. De Pascale MC, Bassi AM, Patrone V, Villacorta L, Azzi A, et al. (2006) Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes. Arch Biochem Biophys 447: 97-106.
49. Atkinson J, Harroun T, Wassall SR, Stillwell W, Katsaras J (2010) The location and behavior of alpha-tocopherol in membranes. Mol Nutr Food Res 54: 641-651.
50. Lemaire-Ewing S, Desrumaux C, Neel D, Lagrost L (2010) Vitamin E transport, membrane incorporation and cell metabolism: Is alpha-tocopherol in lipid rafts an oar in the lifeboat? Mol Nutr Food Res 54: 631-640.
51. Shan L, Noritake S, Fujiwara M, Asano S, Yoshida-Noro C, et al. (2011) Sec14l3 Is Specifically Expressed in Mouse Airway Ciliated Cells. Inflammation.
52. Nell S, Bahtz R, Bossecker A, Kipp A, Landes N, et al. (2007) PCR-verified microarray analysis and functional in vitro studies indicate a role of alpha-tocopherol in vesicular transport. Free Radic Res 41: 930-942.
53. Posor Y, Eichhorn-Gruenig M, Puchkov D, Schoneberg J, Ullrich A, et al. (2013) Spatiotemporal control of endocytosis by phosphatidylinositol-3,4- bisphosphate. Nature 499: 233-237.
54. Schaaf G, Betts L, Garrett TA, Raetz CR, Bankaitis VA (2006) Crystallization and preliminary X-ray diffraction analysis of phospholipid-bound Sfh1p, a member of the Saccharomyces cerevisiae Sec14p-like phosphatidylinositol transfer protein family. Acta Crystallograph Sect F Struct Biol Cryst Commun 62: 1156-1160.
55. Inoue M, Itoh H, Tanaka T, Chun TH, Doi K, et al. (2001) Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol 21: 560-566.
56. Nakai K, Yoneda K, Ishihara Y, Ohmori K, Moriue T, et al. (2011) Lipid peroxidation-induced VEGF expression in the skin of KKAy obese mice. Exp Dermatol 20: 388-393.
57. Ren B, Hale J, Srikanthan S, Silverstein RL (2011) Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway. Blood 117: 6036-6045.
58. Eyre NS, Cleland LG, Tandon NN, Mayrhofer G (2007) Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake. J Lipid Res 48: 528-542.
59. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, et al. (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281: 31002-31011.
60. Cursiefen C, Maruyama K, Bock F, Saban D, Sadrai Z, et al. (2011) Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med 208: 1083-1092.
61. Isenberg JS, Jia Y, Fukuyama J, Switzer CH, Wink DA, et al. (2007) Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem 282: 15404-15415.
62. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, et al. (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177.
63. Moldovan L, Moldovan NI (2005) Role of monocytes and macrophages in angiogenesis. EXS: 127-146.
64. Frantz S, Bauersachs J, Ertl G (2009) Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res 81: 474-481.
65. Marlier A, Schmidt-Ott KM, Gallagher AR, Barasch J, Karihaloo A (2009) Vegf as an epithelial cell morphogen modulates branching morphogenesis of embryonic kidney by directly acting on the ureteric bud. Mech Dev 126: 91-98.
66. Zingg JM, Meydani M, Azzi A (2012) alpha-Tocopheryl phosphate-An activated form of vitamin E important for angiogenesis and vasculogenesis? Biofactors 38: 24-33.
67. Pepper MS, Baetens D, Mandriota SJ, Di Sanza C, Oikemus S, et al. (2000) Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution. Dev Dyn 218: 507-524.
68. Rossiter H, Barresi C, Ghannadan M, Gruber F, Mildner M, et al. (2007) Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J 21: 3994-4004.
69. Bankaitis VA, Mousley CJ, Schaaf G (2010) The Sec14 superfamily and mechanisms for crosstalk between lipid metabolism and lipid signaling. Trends Biochem Sci 35: 150-160.
70. Bankaitis VA, Ile KE, Nile AH, Ren J, Ghosh R, et al. (2012) Thoughts on Sec14-like nanoreactors and phosphoinositide signaling. Adv Biol Regul 52: 115-121.